VGIT vs XLV
Vanguard Intermediate-Term Treasury ETF vs Health Care Select Sector SPDR Fund
VGIT$58.66
Vanguard Intermediate-Term Treasury ETF
Intermediate-term US Treasuries (3–10 years).
Expense: 0.03%Yield: 3.85%
XLV$161.81
Health Care Select Sector SPDR Fund
S&P 500 health care sector.
Expense: 0.08%Yield: 1.60%
Quick take
- • VGIT has the lower expense ratio at 0.03% vs 0.08% for XLV.
- • VGIT pays a higher dividend yield (3.85%).
Side-by-side metrics
| Metric | VGIT | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.08% |
Dividend yield Trailing 12-month yield. | 3.85% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $50.38B | $40.60B |
YTD return | -0.48% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.78 | 0.51 |
P/E ratio | — | 29.12 |
Last price | $58.66 | $161.81 |
Inception | — | — |
Issuer | Vanguard | State Street |
VGIT top holdings
Holdings data unavailable for VGIT.
XLV top holdings
Top holdings · XLV
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
Sector breakdown · XLV
Healthcare100.0%
About VGIT
VGIT (Vanguard Intermediate-Term Treasury ETF) is Intermediate-term US Treasuries (3–10 years). Managed by Vanguard, the fund carries $50.4B in assets under management, an expense ratio of 0.03%, a dividend yield of 3.85%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.